Only a week to go till LSI Europe! We'll see you there!
AVASA (LSI Europe ‘24 Innovator) is setting a new global standard in microsurgery with its revolutionary Avasa Coupler. Designed to simplify and accelerate arterial connections during free flap surgeries, the device eliminates the need for time-consuming, high-risk hand sewing, allowing plastic surgeons to streamline reconstructive procedures for patients with physical deformities caused by cancer treatment, trauma, or congenital conditions. Now raising its Series A to bring this innovation to market, Avasa has achieved several important milestones: • Filed patents in key markets, positioning the company to expand into other high-value surgeries in the future. • Preclinical studies show the Avasa Coupler is 80% faster than the manual sewing method, with a 0% failure rate compared to the 4% typically seen in microsurgery. • Market research reveals strong demand, with 89% of over 100 surgeons surveyed eager to use an arterial coupler, and 88% predicting it will become the new standard of care for arterial connections. • Coding, coverage, and payment are already in place, with hospitals expected to see significant cost savings. • Leading KOLs from Harvard, MD Anderson, and Stanford are backing the product, helping drive market adoption. We’re excited to announce that Founder & CEO, Nandoun Abeysekera has been selected to present Avasa at LSI Europe ‘24 this September 16-20th in Sintra, Portugal. Join us in Portugal to meet with Nandoun and learn more about Avasa.